Gastroenterol. latinoam 2014; Vol 25, Nº 1: 50-54
Autores:
✉ Eduardo Kattan T, Roberto Candia B, Francisco Barrera M.
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and non-alcoholic fatty liver disease
AbstractResumen